HealthEquity delivered a record third quarter for fiscal 2026, with net income of $52 million, 20% growth in Adjusted EBITDA, and 29% growth in non-GAAP net income per share, reflecting the team's focus on helping members better save, spend and invest for health. The company reported a 7% increase in total revenue to $322.2 million and a substantial rise in net income per diluted share to $0.59 from $0.06 a year ago.

HealthEquity delivered solid financial results in Q2 2026 with revenue reaching $325.8M and EPS at $0.68. Net income grew significantly year-over-year, and the company reported record gross margin and adjusted EBITDA as it continues to expand its HSA footprint.

HealthEquity delivered a solid Q1 FY26 with 15% year-over-year revenue growth, improved margins, and significantly higher net income. The company saw gains across all revenue segments and continued to expand its HSA and CDB account base.

HealthEquity delivered a 19% revenue increase in Q4 FY25 compared to the previous year, alongside stable net income and improved non-GAAP EPS. The company saw growth across service, custodial, and interchange revenue streams, and highlighted continued expansion in total accounts and HSA assets.

HealthEquity reported a 21% increase in revenue to $300.4 million, with net income at $5.7 million and non-GAAP net income at $69.4 million. The company saw growth in HSAs to 9.5 million and total accounts to 16.5 million. They repurchased 0.7 million shares for $60 million and raised fiscal year 2025 guidance.

HealthEquity reported strong second-quarter results, with a 23% increase in revenue to $299.9 million and a significant rise in net income to $35.8 million. The company also announced a $300 million stock repurchase program.

HealthEquity reported a strong first quarter with revenue of $287.6 million, an 18% increase year-over-year. Net income rose to $28.8 million, and the company completed the BenefitWallet HSA portfolio acquisition. The company is raising full year guidance.

HealthEquity reported a 12% increase in revenue to $262.4 million for Q4 2024, with net income reaching $26.4 million and non-GAAP net income at $55.0 million. The company's adjusted EBITDA grew by 34% to $98.8 million, reflecting improved operational efficiency. They also delivered fiscal 2024 with a record of nearly $1 billion in revenue as well as over 500 bps expansion in Adjusted EBITDA margin.

HealthEquity reported a 15% increase in revenue to $249.2 million, a net income of $14.7 million, and non-GAAP net income of $52.2 million. The company's HSA count grew to 8.3 million, with total HSA assets reaching $22.6 billion. They also agreed to acquire the BenefitWallet HSA portfolio.

HealthEquity reported strong second-quarter results, marked by revenue growth of 18% year-over-year, reaching $243.5 million. The company's net income was $10.6 million, a significant improvement from the previous year's net loss. Non-GAAP net income also saw a substantial increase, reaching $45.6 million. Key performance indicators such as HSA accounts and total HSA assets also showed positive growth.

HealthEquity reported a 19% increase in revenue, reaching $244.4 million for the first quarter ended April 30, 2023. Net income was $4.1 million, a significant improvement from the previous year's net loss of $13.6 million. The company added 134,000 new HSA members and increased its Adjusted EBITDA margin by 700 basis points year-over-year.

HealthEquity reported a 15% increase in revenue to $233.8 million for the fourth quarter ended January 31, 2023. The company's net loss was $0.2 million, with non-GAAP net income of $31.3 million, or $0.37 per diluted share. Adjusted EBITDA increased by 46% to $73.6 million.

HealthEquity reported a 20% increase in revenue to $216.1 million, a reduced net loss of $1.6 million, and a 20% increase in Adjusted EBITDA to $73.4 million. The company also saw growth in HSAs, total HSA assets, and total accounts.

HealthEquity reported a 9% increase in revenue to $206.1 million, driven by growth in service, custodial, and interchange revenue. The company experienced a net loss of $10.7 million, or $0.13 per diluted share, while non-GAAP net income was $28.1 million, or $0.33 per diluted share. The number of HSAs grew by 26% to 7.5 million, and total HSA assets increased by 33% to $20.5 billion.

HealthEquity's first quarter of fiscal year 2023 showed positive growth in key areas, including revenue, HSAs, and total accounts. The company reported a revenue of $205.7 million, a 12% increase compared to the previous year. There was a net loss of $13.6 million, and a non-GAAP net income of $22.7 million.

HealthEquity reported an 8% increase in revenue for the fourth quarter ended January 31, 2022, reaching $203.3 million. However, the company experienced a net loss of $32.8 million, or $0.39 per diluted share, and a non-GAAP net income of $17.0 million, or $0.20 per diluted share. The company closed its acquisition of Further and agreed to purchase the HealthSavings HSA portfolio.

HealthEquity reported a slight revenue increase to $180.0 million, but experienced a net loss of $5.0 million, contrasting with a net income of $1.8 million in the same quarter last year. Non-GAAP net income was $28.9 million. The company saw a 14% increase in HSAs to 6.2 million and a 32% increase in total HSA assets to $16.4 billion. Key acquisitions of Fifth Third Bank HSA portfolio and Further were completed during and after the quarter.

HealthEquity reported a 7% increase in revenue to $189.1 million for the second quarter ended July 31, 2021. The company's HSA count grew by 11% year-over-year, reaching 6.0 million, and total HSA assets increased by 27% to $15.5 billion. The company reported a net loss of $3.8 million, or $0.05 per diluted share, and non-GAAP net income of $33.4 million, or $0.40 per diluted share.

HealthEquity reported a decrease in revenue and a net loss for the first quarter of fiscal year 2022. While revenue decreased by 3% to $184.2 million, the company saw a 9% increase in the number of HSAs to 5.8 million and a 31% increase in total HSA assets to $15.0 billion. The company also completed its acquisition of Luum and entered into agreements to acquire Further and transition the Fifth Third Bank HSA portfolio.

HealthEquity reported a decrease in revenue by 6% to $188.2 million, but net income increased to $5.4 million. The company's non-GAAP net income was $33.3 million, and it saw growth in HSAs with investments, which increased by 51% year over year.

HealthEquity reported a 14% increase in revenue to $179.4 million and net income of $1.8 million, or $0.02 per diluted share, for the third quarter ended October 31, 2020. The company's HSA count grew by 9% year-over-year to 5.5 million, and total HSA assets increased by 19% to $12.4 billion.

HealthEquity reported a strong second quarter with a 103% increase in revenue to $176.0 million. The company achieved $60.0 million in adjusted EBITDA and sequential growth in HSA assets by over $700 million. They also raised their net synergy target to $80 million.

HealthEquity reported a strong first quarter with a 118% increase in revenue to $190.0 million. The company saw growth in HSAs, total HSA assets, and total accounts. While net income increased, the company withdrew its full-year fiscal 2021 guidance due to the COVID-19 pandemic.

HealthEquity reported a revenue of $201.2 million, a 166% increase compared to Q4 FY19. The company reported a net loss of $0.2 million, and non-GAAP net income of $27.9 million. Total HSAs exceeded 5.3 million, an increase of 34% year over year.